Environmental toxic factors and clinical pattern of Parkinson’s disease
Close
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
301 1
Ultima descărcare din IBN:
2023-05-13 13:33
Căutarea după subiecte
similare conform CZU
616.858+615.9 (1)
Neurology. Neuropathology. Nervous system (971)
General toxicology. General studies of poisons and poisoning (intoxication) (45)
SM ISO690:2012
ROTARU, Lilia. Environmental toxic factors and clinical pattern of Parkinson’s disease. In: Moldovan Medical Journal, 2021, nr. 4(64), pp. 69-71. ISSN 2537-6373. DOI: https://doi.org/10.52418/moldovan-med-j.64-4.21.13
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Moldovan Medical Journal
Numărul 4(64) / 2021 / ISSN 2537-6373 /ISSNe 2537-6381

Environmental toxic factors and clinical pattern of Parkinson’s disease

DOI:https://doi.org/10.52418/moldovan-med-j.64-4.21.13
CZU: 616.858+615.9

Pag. 69-71

Rotaru Lilia
 
Diomid Gherman Institute of Neurology and Neurosurgery
 
Proiecte:
 
Disponibil în IBN: 21 octombrie 2021


Rezumat

Background: Parkinson’s disease (PD) – the most common neuro-degenerative movement disorder – is considered a result of a multifactorial pathogenic process modulated by cumulative and interactive effects of genes and exposures. An environmental exposure could enhance or create dopaminergic neurons vulnerability and increase PD risk. The purpose of the study was to find if excessive exposure to toxic environmental factors may influence clinical pattern of PD. Material and methods: The study was conducted on 111 patients diagnosed with PD, study group being defined as PD exposed to toxins (33 patients), control group including PD patients without toxin exposure (78 patients). General epidemiological data and clinical data were recorded. Results: Toxin exposure was found in 33 patients (29.73%), more of them – men and rural residents. Toxin exposed PD patients had an insignificantly younger age. The most common disease phenotype in the study group was the akinetic-rigid phenotype (64.7%, p = 0.040), bradykinesia being the most common sign at the disease onset (57.6%, p = 0.008). Levodopa equivalent daily dose also was higher in the study group (659.02 ± 232.46, p = 0.042). Conclusions: Excessive exposure to toxic environmental factors may influence the clinical pattern of PD. In this study the akinetic-rigid type was the predominant disease phenotype associated with toxin exposure. Doses needed for treatment were higher in PD patients exposed to toxins, as an indicator of a more severe motor impairment in this group.

Cuvinte-cheie
Parkinson’s disease, toxic environmental factors